Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
Verma, Subodh, Mazer, C. David, Yan, Andrew T., Mason, Tamique, Garg, Vinay, Teoh, Hwee, Zuo, Fei, Quan, Adrian, Farkouh, Michael E., Fitchett, David H., Goodman, Shaun G., Goldenberg, Ronald M., Al-OLanguage:
english
Journal:
Circulation
DOI:
10.1161/CIRCULATIONAHA.119.042375
Date:
August, 2019
File:
PDF, 1.31 MB
english, 2019